ArticleTurkish journal of physical medicine and rehabilitation2026
Effect of ESWT on the microcirculation of the lower extremity in rats with diabetic vasculopathy: An experimental animal study.
Article in Turkish journal of physical medicine and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to investigate the effects of extracorporeal shock wave therapy (ESWT) on the microcirculation of lower extremity skeletal muscle in rats with diabetic vasculopathy (DV) and to elucidate the potential underlying mechanism. Materials and methods: The experimental animal study was conducted between August 2023 and February 2024. Forty healthy adult male Sprague-Dawley rats (mean weight: 226 ± 21 g; range, 205 to 247 g) were randomly assigned to five groups (n=8 per group): Control group (Group A), DV group (Group B), DV + ESWT group (Group C), DV + LY2157299 group (Group D), and DV + ESWT + LY2157299 group (Group E). The blood flow velocity and femoral artery diameter (FAD) on the right lower limb were measured using a high-resolution ultrasound system in all groups. Protein and messenger ribonucleic acid (mRNA) expression of phosphoinositide 3-kinase (PI3K), serine/threonine-protein kinase (AKT), and transforming growth factor-β1 (TGF-β1) in the femoral artery were analyzed using Western blotting and real-time polymerase chain reaction. The expression of CD31 in the gastrocnemius was measured using immunofluorescence. Results: Protein expression of PI3K, AKT, and TGF-β1 was significantly lower in Groups C, D, and E than in Group B (p < 0.001, p < 0.001, and p < 0.001, respectively). The mRNA expression of AKT and TGF-β1 in Groups C, D, and E was significantly lower than that in Group B (p < 0.001, p < 0.001, and p < 0.001, respectively). The expression of CD31 in the gastrocnemius, FAD, and blood flow was significantly higher in Groups C, D, and E than in Group B (p < 0.05), with the highest expression in Group E compared with Groups C and D (p < 0.05). Conclusion: Extracorporeal shock wave therapy can downregulate TGF-β1 expression, inhibit the PI3K/AKT pathway, increase gastrocnemius CD31 expression and lower limb blood flow, and improve blood microcirculation of lower limb skeletal muscle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.